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Context
Cutaneous warts are highly prevalent benign papillomas 
of the skin, of which plantar warts (verrucae plantaris) 
are the most common type. Most warts disappear spon-
taneously, but plantar warts can also be persistent and 
frequently cause discomfort. In the UK, almost 2 million 
people visit their general practitioner (GP) for cutaneous 
warts at a cost of £40M per year.1 A 2006 Cochrane sys-
tematic review of topical treatments for cutaneous warts 
concluded that available trials were of poor methodologi-
cal quality, and that evidence on cryotherapy was con-
tradictory whereas evidence on salicylic acid was more 
convincing.2 Cockayne et al assessed the clinical effec-
tiveness and cost-effectiveness of cryotherapy and sali-
cylic acid for plantar warts.
Methods
Patients aged 12 years and above with one or more plan-
tar warts were recruited from 16 sites (podiatry outpatient 
clinics or GP practices). This pragmatic, multi-centred, 
randomised controlled trial compared liquid nitrogen 
cryotherapy each 14–21 days for a maximum of four 
treatments to once-daily self-treatment with 50% sali-
cylic acid after fi ling for a maximum of 8 weeks. Primary 
outcome was complete clearance of all warts, indepen-
dently assessed from photographs by two blinded asses-
sors at 12 weeks of follow-up. The cost-effectiveness was 
assessed comparing the incremental costs with the incre-
mental benefi ts. Cost-effectiveness acceptability curves 
were plotted.
Findings
A total of 240 patients were randomised. There was 
no difference between the proportions of patients with 
complete clearance of all warts at 12 weeks between 
salicylic acid and cryotherapy groups (14.3% vs 13.6%, 
p=0.89). Although causing more pain, treatment satis-
faction was higher for cryotherapy. Cryotherapy had 
higher mean costs per additional healed patient (£101, 
95% CI £85 to £117), and in light of similar effective-
ness, was dominated by salicylic acid in cost-effective-
ness analyses.
Commentary
This high-quality randomised trial with economic 
evaluation confi rms that for patients aged 12 years and 
above with longstanding plantar warts cryotherapy is 
not more effective and has higher costs than salicylic 
Commentary on: Cockayne S, Curran M, Denby G, et al. EVerT: cryotherapy versus salicylic acid for the 
treatment of verrucae–a randomised controlled trial. Health Technol Assess 2011;15:1–170.
acid self-treatment, though satisfaction was higher with 
cryotherapy. Due to the pragmatic study design, cryo-
therapy was probably used less aggressively than rec-
ommended in literature.2 In contrast, the salicylic acid 
concentration (50%) was probably higher than usual. 
This may have caused a relative underestimation of the 
effect of cryotherapy. Although the authors describe 
problems related to the making and interpretation of 
photographs, primary outcome assessment was suitably 
blinded.
Extrapolation is limited. Only patients aged 12 years 
and above were included, whereas wart incidence is high-
est in children aged 5–14 years.3 Younger patients have 
higher clearance rates, spontaneously as well as after 
treatment.4 Warts on other locations than soles of the feet 
(mostly hands) respond better to treatment, especially to 
cryotherapy.
Only direct medical costs linked to National Health 
Service budget were compared. The costs for cryotherapy 
were based on a higher average number of healthcare 
professional visits (20 min per visit; 3.6 visits for cryo-
therapy vs 1.9 for salicylic acid) and higher equipment/
medication costs per patient (£60.05 vs £8.50, respec-
tively). The calculation did not include indirect costs, 
like time investment to travel to clinics or time spent on 
the daily salicylic acid application procedure. Costs vary 
between healthcare systems and could theoretically also 
change conclusions. However, in a sensitivity analysis an 
extreme decrease of cryotherapy costs was adopted and 
the resulting cost-effectiveness calculation was still in 
favour of salicylic acid.
Recently, another randomised trial from the 
Netherlands4 compared cryotherapy, salicylic acid and a 
wait and see policy in primary care. This trial showed 
that cryotherapy was more effective for common warts 
(mostly on hands). There was no difference between cryo-
therapy, salicylic acid and a wait and see policy for plan-
tar warts. For the subgroup aged 12 years and above with 
plantar warts in this trial clearance rates were comparable 
with current trial.
Because of the relatively low clearance rates, the 
side effects and the related costs, patients with plantar 
warts require detailed information for realistic shared 
decision-making. Future research should not only focus 
on new treatments, but also try to identify subgroups 
of patients that will respond to specifi c treatments, for 
example subgroups based on clinical characteristics of 
the warts or based on different types of infecting human 
papilloma virus.3
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